728 x 90

Blog 1 Column Left Sidebar

  • Home
  •  
  • Blog 1 Column Left Sidebar

Latest Posts

Top Authors

  • Crude Oil Lower; Monthly Demand Reports in Focus

    Crude Oil Lower; Monthly Demand Reports in Focus0

    Oil prices fell Monday, consolidating after last week’s strong gains ahead of the release of demand forecasts from the OPEC and the IEA as well as a deluge of potentially influential economic data due this week. By 04:35 ET (09:35 GMT), U.S. crude futures traded 0.7% lower at $79.55 a barrel, while the Brent contract

    READ MORE
  • Covishield, Covaxin prices likely to be capped at Rs 275 per dose

    Covishield, Covaxin prices likely to be capped at Rs 275 per dose0

    The prices of Covishield and Covaxin could be capped at Rs 275 per dose, with an additional service charge of Rs 150, once the two Covid-19 vaccines get regular market approval from the drug regulator, a report by news agency Press Trust of India said, quoting official sources. The National Pharmaceutical Pricing Authority (NPPA) has

    READ MORE
  • COVID-19: ओडिशा के अस्पताल में Covaxin का मानव परीक्षण शुरू

    COVID-19: ओडिशा के अस्पताल में Covaxin का मानव परीक्षण शुरू0

    कोरोना वायरस  के खिलाफ देश में बने टीके ‘कोवैक्सिन ‘का सोमवार को भुवनेश्वर के इंस्टीट्यूट ऑफ मेडिकल साइंसेस एंड एसयूएम अस्पताल में मानव परीक्षण शुरू हो गया है. Covaxin टीके को भारत बायोटेक ने विकसित किया है. ह्यूमन ट्रायल (मानव परीक्षण) के प्रधान जांचकर्ता डॉक्टर ई वेंकट राव ने कहा कि Covaxin टीका कुछ लोगों

    READ MORE
  • COVID disrupts health services in over 90% of countries: WHO

    COVID disrupts health services in over 90% of countries: WHO0

    Disruptions in basic health services such as vaccination programs and treatment of diseases like AIDS were reported in 92% of 129 countries, a World Health Organization survey on the impact of the COVID-19 pandemic showed on Monday. The survey, conducted in November-December 2021, showed services were “severely impacted” with “little or no improvement” from the

    READ MORE
  • Covaxin की अतिरिक्त 20 करोड़ खुराक का उत्पादन किया जाएगा

    Covaxin की अतिरिक्त 20 करोड़ खुराक का उत्पादन किया जाएगा0

    देश में COVID-19 की रोकथाम के लिए टीकाकरण अभियान जारी है. भारत बायोटेक  ने गुरुवार को कहा कि कंपनी सालाना कोरोनावायरस के टीके कोवैक्सीन  की अतिरिक्त 20 करोड़ खुराक का उत्पादन करेगी. यह घोषणा ऐसे समय में की गई है कि जब कई राज्यों ने वैक्सीन की कमी की बात कही है. कंपनी के इस ऐलान

    READ MORE
  • COVAX Targets 70% COVID-19 Immunization Coverage By Mid-2022

    COVAX Targets 70% COVID-19 Immunization Coverage By Mid-20220

    Geneva, Switzerland:  Amid possible need for variant-specific vaccines, changes to vaccination policies, country preference for some products over others, the programmatic complexity of managing multiple products, and the need for better intelligence on country-level planning and execution, COVAX on Thursday set a target to achieve 70 per cent COVID-19 immunization coverage by mid-2022. The Independent

    READ MORE

Recent Posts

Meta

Top
© Copyright All rights reserved by assam-ind.in